Literature DB >> 21167342

Risk adjustment for in-hospital mortality of contemporary patients with acute myocardial infarction: the acute coronary treatment and intervention outcomes network (ACTION) registry-get with the guidelines (GWTG) acute myocardial infarction mortality model and risk score.

Chee Tang Chin1, Anita Y Chen, Tracy Y Wang, Karen P Alexander, Robin Mathews, John S Rumsfeld, Christopher P Cannon, Gregg C Fonarow, Eric D Peterson, Matthew T Roe.   

Abstract

BACKGROUND: accurate risk adjustment is needed to guide quality improvement initiatives and research to improve care of patients with acute myocardial infarction (MI). We developed and validated a model to predict the risk of in-hospital mortality for contemporary patients with acute MI treated in routine clinical practice.
METHODS: the Acute Coronary Treatment and Intervention Outcomes Network (ACTION) Registry-Get With The Guidelines (GWTG) database of patients with acute MI was used to derive (n = 65,668 from 248 US sites) and validate (n = 16,336) a multivariable logistic regression model to predict the likelihood of in-hospital mortality (4.9% in each cohort).
RESULTS: factors with the highest independent significance in terms of mortality prediction included age, baseline serum creatinine, systolic blood pressure, troponin elevation, heart failure and/or cardiogenic shock at presentation, ST-segment changes, heart rate, and prior peripheral arterial disease. The model showed very good discrimination, with c statistics of 0.85 and 0.84 in the derivation and validation cohorts, respectively. The model calibrated well overall and in key patient subgroups including males versus females, age <75 versus ≥ 75 years, diabetes versus no diabetes, and ST-elevation MI versus non-ST-elevation MI. The ACTION Registry-GWTG in-hospital mortality risk score was also developed from the model. Patients with a risk score of ≤ 40 had an observed mortality rate of <4% compared with those with a risk score of 41-50 (12%) and risk scores >50 (34%).
CONCLUSION: the ACTION Registry-GWTG™ in-hospital mortality model and risk score represent simple, accurate risk adjustment tools for contemporary patients with acute MI.

Entities:  

Mesh:

Year:  2011        PMID: 21167342     DOI: 10.1016/j.ahj.2010.10.004

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  45 in total

1.  Characteristics and in-hospital outcomes of patients with non-ST-segment elevation myocardial infarction and chronic kidney disease undergoing percutaneous coronary intervention.

Authors:  Elias B Hanna; Anita Y Chen; Matthew T Roe; Stephen D Wiviott; Caroline S Fox; Jorge F Saucedo
Journal:  JACC Cardiovasc Interv       Date:  2011-09       Impact factor: 11.195

2.  Early Medication Nonadherence After Acute Myocardial Infarction: Insights into Actionable Opportunities From the TReatment with ADP receptor iNhibitorS: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) Study.

Authors:  Robin Mathews; Eric D Peterson; Emily Honeycutt; Chee Tang Chin; Mark B Effron; Marjorie Zettler; Gregg C Fonarow; Timothy D Henry; Tracy Y Wang
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2015-06-02

3.  Modest Associations Between Electronic Health Record Use and Acute Myocardial Infarction Quality of Care and Outcomes: Results From the National Cardiovascular Data Registry.

Authors:  Jonathan R Enriquez; James A de Lemos; Shailja V Parikh; DaJuanicia N Simon; Laine E Thomas; Tracy Y Wang; Paul S Chan; John A Spertus; Sandeep R Das
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2015-10-20

4.  Performance of Hospitals When Assessing Disease-Based Mortality Compared With Procedural Mortality for Patients With Acute Myocardial Infarction.

Authors:  Ashwin S Nathan; Qun Xiang; Daniel Wojdyla; Sameed Ahmed M Khatana; Elias J Dayoub; Rishi K Wadhera; Deepak L Bhatt; Daniel M Kolansky; Ajay J Kirtane; Sunil V Rao; Robert W Yeh; Peter W Groeneveld; Tracy Y Wang; Jay Giri
Journal:  JAMA Cardiol       Date:  2020-07-01       Impact factor: 14.676

5.  Diagnostic time course, treatment, and in-hospital outcomes for patients with ST-segment elevation myocardial infarction presenting with nondiagnostic initial electrocardiogram: a report from the American Heart Association Mission: Lifeline program.

Authors:  Robert F Riley; L Kristin Newby; Creighton W Don; Matthew T Roe; DaJuanicia N Holmes; Sanjay K Gandhi; Michael A Kutcher; David M Herrington
Journal:  Am Heart J       Date:  2012-11-21       Impact factor: 4.749

6.  Cardiovascular risk factors cause premature rarefaction of the collateral circulation and greater ischemic tissue injury.

Authors:  Scott M Moore; Hua Zhang; Nobuyo Maeda; Claire M Doerschuk; James E Faber
Journal:  Angiogenesis       Date:  2015-04-11       Impact factor: 9.596

7.  Impact of body weight and extreme obesity on the presentation, treatment, and in-hospital outcomes of 50,149 patients with ST-Segment elevation myocardial infarction results from the NCDR (National Cardiovascular Data Registry).

Authors:  Sandeep R Das; Karen P Alexander; Anita Y Chen; Tiffany M Powell-Wiley; Deborah B Diercks; Eric D Peterson; Matthew T Roe; James A de Lemos
Journal:  J Am Coll Cardiol       Date:  2011-12-13       Impact factor: 24.094

8.  Diabetes and Adverse Cardiovascular Outcomes in Patients with Acute Coronary Syndrome - Data from Taiwan's Acute Coronary Syndrome Full Spectrum Data Registry.

Authors:  Cheng-Chun Wei; Kou-Gi Shyu; Jun-Jack Cheng; Hei-Ming Lo; Chiung-Zuan Chiu
Journal:  Acta Cardiol Sin       Date:  2016-01       Impact factor: 2.672

9.  Race and Sex Differences in Management and Outcomes of Patients After ST-Elevation and Non-ST-Elevation Myocardial Infarct: Results From the NCDR.

Authors:  D Edmund Anstey; Shuang Li; Laine Thomas; Tracy Y Wang; Stephen D Wiviott
Journal:  Clin Cardiol       Date:  2016-07-28       Impact factor: 2.882

10.  ED administration of thienopyridines in non-ST-segment elevation myocardial infarction: results from the NCDR.

Authors:  Deborah B Diercks; Michael C Kontos; Judd E Hollander; Bryn E Mumma; DaJuanicia N Holmes; Stephen Wiviott; Jorge F Saucedo; James A de Lemos
Journal:  Am J Emerg Med       Date:  2013-05-20       Impact factor: 2.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.